Back to Startups

Altera Biosciences

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
@AlteraBiosci Website LinkedIn Cape Town, South Africa
About Altera Biosciences

Developing universal donor cell therapies that bypass immune rejection.

Business Information
Target Customers
hospitals biotech companies research institutions
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model B2B partnerships and licensing
Pricing Strategy N/A
Sales Channels direct sales, partnerships
Funding Timeline
Round Date Amount Investors
Pre-Seed Aug 02, 2025 $1.6M OneBio
Founders
A
Alexandra Miszewski

Co-Founder & CEO

Investors
O
OneBio

Venture Capital

Recent Mentions
SR_Africa
Startup Researcher Africa @SR_Africa
Aug 02, 2025

Altera Biosciences has raised $1.6M in pre-seed funding to develop universal donor cell therapies that bypass immune rejection. Led by Alexandra Miszewski, the Cape Town-based startup is Africa’s first venture dedicated to cell and gene therapy. The round is backed by OneBio https://t.co/MRlEwSd9Hd

View on Twitter
Similar Startups
Alaunos Therapeutics, Inc.
89% match

Alaunos Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapie...
One Biosciences
88% match

One Biosciences is a biotechnology company focused on innovative solutions in the life sciences sect...
AusperBio
87% match

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
Alpheus Medical
87% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...